Literature DB >> 13148346

Observations concerning the production and excretion of cholesterol in mammals. XII. Demonstration of the essential role of hepatic reticulo-endothelial cell (Kupffer cell) in the normal disposition of exogenously derived cholesterol.

M FRIEDMAN, S O BYERS, R H ROSENMAN.   

Abstract

Entities:  

Keywords:  CHOLESTEROL/metabolism; LIVER/metabolism

Mesh:

Substances:

Year:  1954        PMID: 13148346     DOI: 10.1152/ajplegacy.1954.177.1.77

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


× No keyword cloud information.
  7 in total

1.  Hepatic metabolism of cholesterol in experimental nephrosis in rats.

Authors:  R H ROSENMAN; W BREALL; S O BYERS; D D RABIN
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  Effects of dextran, polyvinylpyrrolidone and gamma globulin on the hyperlipidemia of experimental nephrosis.

Authors:  J C ALLEN; J H BAXTER; H C GOODMAN
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

3.  The distribution of cholesterol and total lipids in the nephrotic rat.

Authors:  R H ROSENMAN; M FRIEDMAN; S O BYERS
Journal:  J Clin Invest       Date:  1955-05       Impact factor: 14.808

4.  The removal of 14C-labelled chylomicron fat from the circulation in rats.

Authors:  J E FRENCH; B MORRIS
Journal:  J Physiol       Date:  1957-09-30       Impact factor: 5.182

5.  Observations concerning the production and excretion of cholesterol in mammals. XVI. The relationship of the liver to the content and control of plasma cholesterol ester.

Authors:  M FRIEDMAN; S O BYERS
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

6.  Adult liver parenchymal cells in primary culture characteristics and cell recognition standards.

Authors:  R J Bonney
Journal:  In Vitro       Date:  1974 Jul-Aug

7.  The metabolism of chylomicra. I. The removal of palmitic acid-1-C14 labeled chylomicra from dog plasma.

Authors:  D S FREDRICKSON; R J HAVEL
Journal:  J Clin Invest       Date:  1956-09       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.